Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Trivalent GBS Vaccine in Pregnant Women
NCT02046148Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2014
- Primary completion
- Dec 2015
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of group b streptococcus trivalent vaccine in Group B streptococcal disease (GBS), sponsored by GSK. Started Mar 2014; status: completed.
02
Drugs
group b streptococcus trivalent vaccine
03
Conditions
Group B streptococcal disease (GBS)
Beyond the preview
Go deeper on NCT02046148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02046148.